Scott A Persohn Selected Research

Apolipoproteins

5/2024	Assessment of neurovascular uncoupling: APOE status is a key driver of early metabolic and vascular dysfunction.
12/2023	Assessment of Neurovascular Uncoupling: APOE Status is a Key Driver of Early Metabolic and Vascular Dysfunction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Scott A Persohn Research Topics

Disease

6	Alzheimer Disease (Alzheimer's Disease) 05/2024 - 01/2022
2	Dementia (Dementias) 05/2024 - 12/2023
2	Amyloid Plaque 01/2022 - 12/2020
1	Postpartum Hemorrhage 01/2021
1	Placenta Accreta 01/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 12/2017
1	Neoplasms (Cancer) 12/2017
1	Hemorrhage 10/2017
1	Shock 10/2017
1	Pulmonary Embolism 04/2017
1	Pulmonary Hypertension 04/2017
1	Vascular Remodeling 04/2017
1	Ganglion Cysts (Ganglion) 01/2017
1	Cardiac Arrhythmias (Arrythmia) 01/2017

Drug/Important Bio-Agent (IBA)

2	ApolipoproteinsIBA 05/2024 - 12/2023
2	Levetiracetam (Keppra)FDA LinkGeneric 12/2023 - 01/2023
1	Apolipoprotein E4IBA 03/2024
1	Apolipoproteins E (ApoE)IBA 12/2023
1	verubecestatIBA 01/2022
1	SugarsIBA 01/2022
1	Amyloid beta-PeptidesIBA 12/2020
1	Proteins (Proteins, Gene)FDA Link 12/2020
1	Amyloid (Amyloid Fibrils)IBA 12/2020
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2017
1	TransferasesIBA 12/2017
1	Histones (Histone)IBA 12/2017
1	Sunitinib (Sutent)FDA Link 12/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2017
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 01/2017

Therapy/Procedure

1	Hysterectomy 01/2021
1	Lithotripsy (Extracorporeal Shockwave Lithotripsy) 10/2017
1	Sympathectomy (Sympathectomies) 01/2017